DB
CDTX

Danske Bank’s Cidara Therapeutics CDTX Stock Holding History

Danske Bank’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$22.1K – 1241
2025
Q4 		$22.1K Buy
+100
New +$16.2K ﹤0.01% 1178

Danske Bank's CDTX Position: Q1 2026 in Review

Danske Bank sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 100 shares — an estimated $22.1K sold.

Danske Bank first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $22.1K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Danske Bank reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 100 Cidara Therapeutics shares in Q1 2026, an estimated $22.1K.
  • Danske Bank first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
  • Danske Bank's Cidara Therapeutics position peaked at $22.1K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.